Cost-effectiveness and budget impact of the microprocessor-controlled knee C-Leg in transfemoral amputees with and without diabetes mellitus.
Alexander KuhlmannHenning KrügerSusanne SeidingerAndreas HahnPublished in: The European journal of health economics : HEPAC : health economics in prevention and care (2020)
Results of the study suggest that the C-Leg provides substantial additional health benefits compared with NMPKs and is likely to be cost-effective in transfemoral amputees with DM as well as in amputees without DM at an ICER threshold of 40,000 Euro per QALY gained.